Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Mutations affecting segment number and polarity in Drosophila.
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination.
Neurofilament light antibodies in serum reflect response to natalizumab treatment in multiple sclerosis.
Endogenous opioids regulate the expression of inducible nitric oxide synthase by splenocytes.
Association mapping of disease loci, by use of a pooled DNA genomic screen.
Potential T cell epitopes of Mycobacterium tuberculosis that can instigate molecular mimicry against host: implications in autoimmune pathogenesis.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Natalizumab in progressive MS: Results of an open-label, phase 2A, proof-of-concept trial.
MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.
MRI in multiple sclerosis: a review of the current literature.
Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
From "Wheelchair Circuit" to "Wheelchair Assessment Instrument for People with Multiple Sclerosis": Reliability and Validity Analysis of a Test to Assess Driving Skills in Manual Wheelchair Users With Multiple Sclerosis.
ATX-MS-1467 - Positive Immunological data in Multiple Sclerosis: Final Phase I/IIa data shows safety and tolerability, plus efficacy
No impact of current therapeutic strategies on disease reactivation after natalizumab discontinuation: a comparative analysis of different approaches during the first year of natalizumab discontinuation.
Unraveling the secrets of white matter - Bridging the gap between cellular, animal and human imaging studies.
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Early Growth Response Gene-2 Controls IL-17 Expression and Th17 Differentiation by Negatively Regulating Batf.
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Vinpocetine inhibits oligodendroglial precursor cell differentiation.
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis

Pages